Getting latest data loading
Home / Morning Report / Morning Report

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 7 January 2022

Yesterday’s UK 100 Leaders Price (p) % Chg
STANDARD CHARTERED PLC 477.1 3.7%
NATWEST GROUP PLC 242.7 2.2%
HSBC HOLDINGS PLC 477.9 2.0%
LLOYDS BANKING GROUP PLC 51.7 2.0%
BRITISH AMERICAN TOBACCO PLC 2,819.5 1.0%

 

Yesterday’s UK 100 Laggards Price (p) % Chg
AVEVA GROUP PLC 3146.0 -5.1%
DECHRA PHARMACEUTICALS PLC 4568.0 -4.8%
FLUTTER ENTERTAINMENT PLC-DI 11300.0 -4.5%
RELX PLC 2244.0 -4.5%
HALMA PLC 2996.0 -4.4%
Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 7,445 -1.0% 9.2%
DOW JONES INDUS. AVG 36,279 -0.4% 17.7%
DAX INDEX 16,050 -1.4% 15.9%
NIKKEI 225 28,488 -2.9% 3.6%
S&P/ASX 200 INDEX 7,358 -2.7% 9.6%
Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 79.53 2.16%
Brent Crude (ICE) USD/bbl. 82.07 1.57%
Gold Spot USD/t oz. 1,791 -1.1%
Copper (Comex) USd/lb. 434 -1.7%
The UK 100 is called to open flat today at 7450.

4 hours; 10 Months

Click graph to enlarge

Markets Overview:

 

 

The UK 100 is called to open flat today at 7450.  A broadly unchanged open is expected this morning ahead of todays US jobs data.  Expectations are for December payrolls to improve to 420k, and the unemployment rate to fall further to 4.1%, although some estimates for payrolls have come in as high as 900m.  Stateside yesterday saw US markets were weak, with the Dow Jones declining 171 points to 36,236 and the S&P 500 dipping 5 points to 4,695.  In Asia this morning, Japan’s Nikkei 225 is trading around 9 points lower at 28,479 while in Hong Kong the Hang Seng is 371 points to the good at 23,444.

 

 

Company News & Broker Comments:

 

 

Company News:

Aston Martin says they are on track for £2bn revenue and £500m adjusted EBITDA by 2024-25 as they state they have £420m cash balance at year-end, above expectations.

 

 

Clarkson says trading during December was stronger than anticipated as they expect underlying profit before tax for 2021 to be not less than £69m.

 

 

GlaxoSmithKline has signed agreements with the Canadian government to supply 20,000 more doses of its COVID-19 drug as the country battles a surge of infections driven by the Omicron variant.

 

 

Royal Dutch Shell said its $7bn share buyback programme, of which $1.5bn has been completed, will continue “at pace” despite a slowdown in fuel demand due to the Omicron OCVID-19 variant. They expect Q4 oil products sales volume to be between 4-5m boepd.

 

 

Smiths completes sales of Smiths Medical to ICU Medical for around $2.7bn.

 

Broker Comments

Berenberg Upgrades Centamin to Buy from Hold (5 Buys / 3 Holds / 1 Sell)

 

 

Berenberg Upgrades Rio Tinto to Buy from Hold (6 Buys / 10 Holds / 3 Sells)

 

 

Exane BNP Downgrades Royal Dutch Shell to Neutral (20 Buys / 2 Holds / 2 Sells)

 

 

Liberum Upgrades Centamin to Buy from Sell (5 Buys / 3 Holds / 1 Sell)

 

 

Morgan Stanley Downgrades ITV to Equal-Weight from Overweight (5 Buys / 5 Holds / 0 Sells)

 

 

Reporting Today:

 

 

None

 

 

Reporting Monday:

 

 

None

 

 

In Focus Today:

 

 

EU Consumer Confidence

EU Consumer Price Index

EU Industrial Confidence

US Nonfarm Payrolls

 

 

Next Week’s Ex-Dividends:

 

FTSE 100:

 

Next

SSE

Sage Group

Ashtead Group

 

FTSE 250:

 

Primary Health Properties

Shaftesbury

Dr. Martens

Future

 

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.